ARCHIVES

Rituximab Prolonged Survival Of CLL In Phase III Study

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

AIDS Biological Specimens Available From NIH

November 22, 1985

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

Analysis Shows No Mortality Benefit From Regular PSA Screening

January 27, 2012